[ON THE DEVELOPMENT OF RADIOACTIVE DRUGS].
Explore the source record for details and available documents.
Antifibrinolytic Agents↗
Biomedical subjects
J S MITCHELL
Publications and source records attributed to J S MITCHELL.
INVESTIGATION OF A RADIOACTIVE DRUG (TRA 119) WITH SPECIAL REFERENCE TO AUTORADIOGRAPHIC AND RELATED STUDIES.
Explore the source record for details and available documents.
Antineoplastic Agents↗
AN ATTEMPT TO DEVELOP A RADIOACTIVE DRUG FOR CANCER THERAPY.
Explore the source record for details and available documents.
Antineoplastic Agents↗
Laboratory and clinical studies of some quinol diphosphates and related compounds as chemical radiosensitizers and the development of a radioactive drug.
Explore the source record for details and available documents.
Biomedical Research↗
Some recent laboratory studies of chemical radiosensitizers.
Explore the source record for details and available documents.
Animals↗
Clinical and laboratory studies of the therapeutic possibilities of tritiated synkavit, mainly by intra-arterial administration.
Explore the source record for details and available documents.
Antifibrinolytic Agents↗
A study of dose levels in radio-iridium gamma-ray therapy.
Explore the source record for details and available documents.
Iridium↗
Some clinical and laboratory studies of chemical radiosensitizers.
Explore the source record for details and available documents.
Animals↗
The bone marrow in malignant disease.
Explore the source record for details and available documents.
Bone Marrow↗
Carcinoma of the skin appearing 49 years after a single diagnostic roentgen exposure; report of a case.
Explore the source record for details and available documents.
Carcinoma↗
Laboratory studies and clinical radiotherapeutic trials of some chemical radio-sensitisers.
Explore the source record for details and available documents.
Animals↗
Clinical assessment of tetra-sodium 2-methyl-1: 4-naphthohydroquinone diphosphate as a radiosensitiser in the radiotherapy of malignant tumours.
Explore the source record for details and available documents.
Animals↗
Experience with the 30 MeV synchrotron as a radiotherapeutic instrument. I. Development, calibration and instrumentation.
Explore the source record for details and available documents.
Calibration↗
Experience with the 30 MeV synchrotron as a radiotherapeutic instrument. II. Dosimetry and relevant physical measurements.
Explore the source record for details and available documents.
Humans↗
Experience with the 30 MeV synchrotron as a radiotherapeutic instrument. III. Approach to clinical use.
Explore the source record for details and available documents.
Humans↗
Experiments on the mechanism of action of tetra-sodium 2-methyl-1 : 4. naphthohydroquinone diphosphate as a mitotic inhibitor and radiosensitiser, using the technique of tissue culture. Experimental methods and quantitative results.
Explore the source record for details and available documents.
Animals↗
Experiments on the mechanism of action of tetrasodium 2 - methyl - 1 : 4- naphthohydroquinone diphosphate as a mitotic inhibitor and radiosensitiser, using the technique of tissue culture: relation between cytological effects and chemical constitution.
Explore the source record for details and available documents.
Cell Division↗